Mumbai: The SOTAX Group (SOTAX) and also Ortiv-Q3 (Ortiv) are very happy to announce their cooperation to further increase their capacities in the sphere of Pharma Services. Throughout a vast majority investment in to the equity of Ortiv, SOTAX perhaps not just reinforces its reach into some significant geographical field but also gains use of new technical capacities and tools which can be made up over Ortiv. Ortiv during this partnership fortifies its own position to raise and perform over gains and average access to the worldwide business network of SOTAX.

New assumptions of 10.000 sq ft (approximately 1.000 m 2 ), will probably be installed at the coming weeks in Ahmedabad, India, also a fresh, advanced infrastructure including modern workspace and collection of latest tools to do cGMP analytical services having a transparent focus on complex dose kinds characterization and evidence of concept of formulations. The infrastructure will ease hastening complex formula development application of worldwide customers and will utilize higher throughput to carry out exceptional services to the clients.

“With this collaboration, SOTAX has been strengthen its leading position being a comprehensive solution provider within the international market and we’re of the opinion that the adopted strategy will likely be good for our clients, Ortiv in addition to SOTAX. We’re of the opinion this would have been an extremely successful alliance” says Rolf Benz, CEO, and President of this Board of SOTAX Group.

“We’re of the opinion that collaboration will raise the accomplishment of Ortiv and certainly will lift the Business into the next degree. We see tremendous potential within the subject of Pharma Services particularly in the area of complex services and products in India with the investment of SOTAX in our company, we’re of the opinion this is going to be successful story from the coming decades ” Highlighted Pawan Gupta, Mukesh Kumar and also Sadhana Gupta co founders of all Ortiv.

“We are pleased to bring all Ortiv-Q3 employees with their experience and their innovative ideas on board and to further develop the business of our Pharma Services division in order to continue to offer our customers best-in-class services, with an extremely high level of expertise and quality” remarked Samir Haddouchi, Managing Director of SOTAX Pharma Services.

About SOTAX:

The SOTAX Group is the leading worldwide provider of complete testing solutions for both Development and Research (R&D), Quality Control (QC), and also In-Process Control (IPC) branches of the pharmaceutical trade. SOTAX’s tools, applications, and services have been known with their own clients worldwide while the market standard for Best in Class solutions. It’s likewise the only real analytical services supplier specialized in R&D for both dissolution and discharge testing. The business is providing a high degree of expertise for advanced dose form analyzing in addition to an FDA-inspected centre for regular cGMP testing. Its labs, located throughout the planet, are operating for customers worldwide which range from makers to big cyberspace including generic.

About Ortiv-Q3:

Even the Ortiv company, based by passionate and expert pharma professionalsthat provides an entire suite of drug release testing to get many different dosage forms which range from simple pills to complex formulas like micro-spheres, suspensions, emulsions, nano-dispersions, liposomal and topical formulas. Additionally, Ortiv provides Invitro permeation studies for external and powerful orals. The business comes with advanced and innovative tools such as microdialysis and oral formulas permeation assessment system, that may minimize the probability of bio-failures.